Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity

Covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity

US Patent 7811577 · Granted Oct 12, 2010

Estimated economic value: $104,397,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PCSK9 antagonist compounds2025
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024
Cyclic polypeptides for PCSK9 inhibition2024
Cyclic polypeptides for PCSK9 inhibition2024
Antibody peptide conjugates that have agonist activity at both the glucagon and 2023
Modified lipidated relaxin B chain peptides and their therapeutic use2023
Long-acting co-agonists of the glucagon and GLP-1 receptors2023
Cyclic polypeptides for PCSK9 inhibition2022
Cyclic polypeptides for PCSK9 inhibition2022
Long-acting co-agonists of the glucagon and GLP-1 receptors2022
Long-acting co-agonists of the glucagon and GLP-1 receptors2022
PCSK9 antagonist compounds2022